Last mentioned: Mar 12, 2026
Ipsen has appointed Michelle C. Werner as Executive Vice President and President of North America, effective March 2026. A veteran of AstraZeneca and former CEO of Alltrna, Werner is tasked with accelerating growth in Ipsen's largest market across its oncology, rare disease, and neuroscience portfolios.
Ipsen has appointed industry veteran Michelle C. Werner as Executive Vice President and President of North America, effective immediately. Werner, who joins from Flagship Pioneering and Alltrna, will oversee the company's largest geographic market as it accelerates its specialty care strategy in oncology and rare diseases.
Ipsen has appointed Michelle C. Werner as Executive Vice President and President of North America to spearhead its growth in the region. Werner brings extensive biopharmaceutical leadership experience to the role as the company seeks to strengthen its specialty care portfolio.